EVMN EVOMMUNE
Health Care · Russell 2000
Next earnings: Mon 16 Nov 2026 · estimated
What 18 analyst firms say about EVOMMUNE: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
15 rated views · 18 analyst/firm records · 18 firms
Radar score
- Russell 2000 · Top Picks · 6MBelow the Radar threshold of 8066
- Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8042
Recent analyst activity · last 90 days
Our tracked history has 12 reports on EVMN from 10 analyst firms in the last 90 days (18 firms in the past year).
Comparing each firm's latest target with its previous one: 2 lowered it, 4 left it unchanged and 1 has its first observed target in the past year.
No firm's latest available rating differs from its previous one.
Latest observed target change: RBC Capital lowered its target from $48.00 (set 10 Apr 2026) to $21.00 on 9 Sep 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Cantor Fitzgerald | Prakhar Agrawal | Buy | 18 Sep 2026 | — |
| Clear Str | Unnamed analyst | Buy | 17 Mar 2026 | — |
| Clear Street | Unnamed analyst | Buy | 18 Mar 2026 | 53.00 USD |
| Clear Street LLC | Kaveri Pohlman | Buy | 29 Jun 2026 | 23.00 USD |
| Evercore ISI | Gavin Clark-Gartner | Buy | 2 Jul 2026 | 22.00 USD |
| Goldman Sachs | Unnamed analyst | Buy | 7 Jan 2026 | — |
| H.C. Wainwright | Mitchell S Kapoor | Hold | 5 Oct 2026 | — |
| Leerink Partners | Thomas Smith | Buy | 9 Sep 2026 | 22.00 USD |
| Morgan Stanley | Judah Frommer | Buy | 20 Oct 2026 | 26.00 USD |
| Needham | Serge Belanger | Buy | 26 Aug 2026 | 28.00 USD |
| Oppenheimer | Unnamed analyst | Buy | 7 Apr 2026 | 50.00 USD |
| Raymond James | Martin Auster | Buy | 29 Jun 2026 | 18.00 USD |
| RBC Capital Markets | Brian Abrahams | Buy | 9 Sep 2026 | 21.00 USD |
| Stifel | Alex Thompson | — | 9 Sep 2026 | 30.00 USD |
| UBS | Alice Nettleton | Hold | 11 Oct 2026 | 8.00 USD |
| Weiss Ratings | Unnamed analyst | — | 11 Sep 2026 | — |
| William Blair | Matt Phipps | ConflictConflicting reports · excluded | 29 Jun 2026 | — |
| Data feed RESEARCH | Research Team | Hold | 15 Jul 2026 | — |
Partial coverage · checked 6 Nov (6 Nov 2026, 08:14 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.